Keep Desiccated Thyroid as a Treatment Option for Hypothyroidism Keep Desiccated Thyroid as a Treatment Option for Hypothyroidism
Time spent in normal thyroid range over 3 years was the same whether patients took levothyroxine or desiccated thyroid; editorial says keeping the latter in the treatment tool kit is important.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 22, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Two Lots of NP Thyroid ®, Thyroid Tablets, USP Due to Sub Potency
Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid ®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level. The products are being recalled because testing has found these lots to be sub potent. The product may have (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 18, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Effect of Increased Levothyroxine Dose on Depressive Mood Effect of Increased Levothyroxine Dose on Depressive Mood
Increased doses of levothyroxine may help improve depressive symptoms among older hypothyroid patients receiving hormone replacement therapy.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 1, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Lannett Announces Launch Of FDA Approved Levothyroxine Tablets
PHILADELPHIA, Aug. 3, 2020 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced the launch of Cediprof, Inc.'s FDA approved Levothyroxine Sodium Tablets USP, under the companies recently announced interim exclusiv... Biopharmaceuticals, Endocrinology, Product Launch Lannett, Levothyroxine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 3, 2020 Category: Pharmaceuticals Source Type: news

Levothyroxine: No LV Benefit in Subclinical Hypothyroidism With MI Levothyroxine: No LV Benefit in Subclinical Hypothyroidism With MI
Screening for and subsequent treatment of subclinical hypothyroidism in patients with acute MI to preserve left ventricular function is not justified, the ThyrAMI-2 trialists conclude.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 24, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Thyroid Drug May Not Help After Heart Attack: Study
TUESDAY, July 21, 2020 -- If a heart attack survivor also has an underactive thyroid, treating them with supplemental thyroid hormone probably won't help, new research shows. The study found that use of the hormonal drug, called levothyroxine,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 21, 2020 Category: General Medicine Source Type: news

Bestselling Author Releases Free Deep Dive Educational Webinar and...
Nationally-known patient advocate and bestselling author Mary Shomon has launched a free educational program on levothyroxine, the most commonly prescribed medication to treat hypothyroidism, and one...(PRWeb July 21, 2020)Read the full story at https://www.prweb.com/releases/bestselling_author_releases_free_deep_dive_educational_webinar_and_book_on_levothyroxine_the_most_prescribed_medication_for_hypothyroidism/prweb17267808.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 21, 2020 Category: Pharmaceuticals Source Type: news

Over 158 applications for generic products pending with USFDA for approval: Lupin
Sharing information with company's shareholders, Lupin MD Nilesh Gupta and CEO Vinita Gupta said the company's US business stabilised last fiscal and saw an increase of 5 per cent on the back of products like Levothyroxine and Oseltamivir. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 20, 2020 Category: Pharmaceuticals Source Type: news

Common Treatment, Synthroid, May Not Help Seniors With Subclinical Thyroid
MONDAY, May 4, 2020 -- The medication Synthroid (levothyroxine) is often used to treat a condition called subclinical hypothyroidism, but a new study suggests the treatment might be a waste of time. For the study, researchers followed 638 people... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 4, 2020 Category: General Medicine Source Type: news

Synthroid May Not Help Seniors With Subclinical Thyroid
MONDAY, May 4, 2020 -- The medication Synthroid (levothyroxine) is often used to treat a condition called subclinical hypothyroidism, but a new study suggests the treatment might be a waste of time. For the study, researchers followed 638 people... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 4, 2020 Category: General Medicine Source Type: news

Testing, Prescribing Increase After Change to TSH Reference Range
MONDAY, May 4, 2020 -- A minor planned decrease in the upper limit of the reference range for thyroid-stimulating hormone (TSH) resulted in an increase in levothyroxine prescriptions and more TSH measurements, according to a study published in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 4, 2020 Category: Pharmaceuticals Source Type: news

Levothyroxine Sodium Tablets - In Vivo Pharmacokinetic and Bioavailability Studies and In Vitro Dissolution Testing
Clinical/Medical (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 24, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Patients Say Desiccated Thyroid Better Than Standard Therapy Patients Say Desiccated Thyroid Better Than Standard Therapy
Patients with hypothyroidism taking desiccated thyroid extract such as Armour perceive it works better than synthetic levothyroxine alone, despite lack of data and known risks.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 15, 2020 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

Patients Say Dessicated Thyroid Better Than Standard Therapy Patients Say Dessicated Thyroid Better Than Standard Therapy
Patients with hypothyroidism taking desiccated thyroid extract such as Armour perceive it works better than synthetic levothyroxine alone, despite lack of data and known risks.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 13, 2020 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

Does Thyroid Hormone Therapy in Older Age Increase Risk of Death? Does Thyroid Hormone Therapy in Older Age Increase Risk of Death?
Whether or not the mortality finding is real, one expert says, in any case, levothyroxine doesn't make older patients with subclinical hypothyroidism feel any better, so is unwarranted.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 6, 2020 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

ENDO: Thyroid Hormone Use May Up Mortality Risk in Older Adults
TUESDAY, March 31, 2020 -- Synthetic levothyroxine (LT4) is associated with an increased risk for death among older adults, according to a study presented at the virtual meeting of The Endocrine Society, held from March 28 to 31. Enoch Joseph... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 31, 2020 Category: Pharmaceuticals Source Type: news

Levothyroxine taken in the evening may have greater benefits
Hypothyroidism drug, lethothyroxine, may have greater benefits when taken at bedtime rather than breakfast, according to a study published inClinical Endocrinology.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - March 4, 2020 Category: Endocrinology Source Type: news

Tirosint-Sol (Levothyroxine Sodium Oral Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 2, 2020 Category: Drugs & Pharmacology Source Type: news

Class 2 Medicines Recall: Wockhardt UK Ltd, Levothyroxine 100micrograms/5ml Oral Solution
Wockhardt UK Ltd is recalling specific batches of... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - January 30, 2020 Category: Drugs & Pharmacology Source Type: news

Levothyroxine-induced Liver Injury Levothyroxine-induced Liver Injury
Drug-induced liver injury is rarely observed with levothyroxine therapy; this case demonstrates that it can be reversible with cessation of the drug.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 21, 2020 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Jury Still Out on Whether to Treat Subclincal Hypothyroidism in Elderly Jury Still Out on Whether to Treat Subclincal Hypothyroidism in Elderly
A new systematic review suggests elderly patients with overt hypothyroidism should receive levothyroxine treatment, but for those with subclinical hypothyroidism, the advice is less certain.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 13, 2019 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news

Jury Still Out on Whether to Treat Subclinical Hypothyroidism in Elderly Jury Still Out on Whether to Treat Subclinical Hypothyroidism in Elderly
A new systematic review suggests elderly patients with overt hypothyroidism should receive levothyroxine treatment, but for those with subclinical hypothyroidism, the advice is less certain.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 13, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

' Growing Concern': Incorrect Doses of Compounded Levothyroxine'Growing Concern': Incorrect Doses of Compounded Levothyroxine
"Dramatic" variations in the amount of active ingredient were found in compounded liquid versions of levothyroxine (LT4) in a new study. The"surprise" results are a cause for concern, say researchers.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - November 13, 2019 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

Mifepristone Increases TH Requirements in Hypothyroidism Mifepristone Increases TH Requirements in Hypothyroidism
Treatment with mifepristone resulted in increased levothyroxine requirements among patients with Cushing disease and central hypothyroidism.Journal of the Endocrine Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 14, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Outcome in Heart Failure Treated With Levothyroxine Outcome in Heart Failure Treated With Levothyroxine
A new study examines the long-term effects of levothyroxine treatment in patients with heart failure. What have we learned?Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 2, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Lannett Enters Into Distribution Agreement For Levothyroxine
PHILADELPHIA, July 8, 2019 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into a future exclusive supply and distribution agreement for the approved Levothyroxine Sodium Tablets USP of Ce... Biopharmaceuticals, Generics, Distribution Lannett Company, Levothyroxine, Cediprof, Neolpharma Pharmaceutical Group (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 8, 2019 Category: Pharmaceuticals Source Type: news

Generic vs Brand-Name Levothyroxine: Same Cardiac Event Risk? Generic vs Brand-Name Levothyroxine: Same Cardiac Event Risk?
' There's been a lot of discussion of generic versus brand L-T4, and this is just one other piece of information in a very large group of patients, but it needs follow-up studies,'says lead author.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - July 2, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Similar CV Event Rates Seen for Generic, Brand Levothyroxine
THURSDAY, June 27, 2019 -- Cardiovascular event rates are similar for patients with newly treated hypothyroidism receiving generic and brand levothyroxine (L-T4), according to a study published online April 26 in the Mayo Clinic Proceedings. Robert... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 27, 2019 Category: Pharmaceuticals Source Type: news

Over-prescribed levothyroxine: Mayo Clinic Radio Health Minute
The most commonly prescribed drug in the U.S. also may be one of the most overprescribed for older individuals. Levothyroxine is a medication used to treat low thyroid hormone levels. However, a study published this spring in the New England Journal of Medicine reported that patients with subclinical thyroid hormone levels received no benefit from the drug. Mayo [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 21, 2019 Category: Databases & Libraries Source Type: news

Study finds similar cardiovascular outcomes for generic, brand-name drugs for hypothyroidism
JACKSONVILLE, Fla. -- A new study by Mayo Clinic researchers may have broad implications for treatment of patients with predominantly benign thyroid disease and newly treated hypothyroidism. The study, to be published in Mayo Clinic Proceedings in July, looked at whether generic and brand-name levothyroxine therapy affected hospitalization for cardiovascular events for those patients who [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 19, 2019 Category: Databases & Libraries Source Type: news

Westminster Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Levothyroxine and Liothyronine (Thyroid Tablets, USP) Due to Risk of Adulteration
Westminster Pharmaceuticals, LLC is voluntarily recalling all lots, within expiry, of Levothyroxine and Liothyronine (Thyroid Tablets, USP) 15 mg, 30 mg, 60 mg, 90 mg,& 120 mg to the wholesale level. These products are being recalled as a precaution because they were manufactured using active pharmaceutical ingredients that were sourced prior to the FDA ’s Import Alert of Sichuan Friendly Pharmaceutical Co., Ltd., which as a result of a 2017 inspection were found to have deficiencies with Current Good Manufacturing Practices (cGMP). Substandard cGMP practices could represent the possibility of risk being introduc...
Source: FDA Center for Drug Evaluation and Research - What's New - May 24, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Why doctors now warn against routinely treating mild thyroid issues
Giving daily levothyroxine pills to people with a mild abnormality called subclinical hypothyroidism offers no benefit, a review of 21 clinical trials suggests. (Source: CBC | Health)
Source: CBC | Health - May 17, 2019 Category: Consumer Health News Tags: News/Health Source Type: news

Mild Hypothyroidism Being Overtreated, Avoid Pills, Says Panel Mild Hypothyroidism Being Overtreated, Avoid Pills, Says Panel
In a"strong recommendation," an international panel of experts advise that patients with subclinical hypothyroidism should not be routinely prescribed levothyroxine; evidence shows few benefits.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - May 16, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Hundreds of thousands of people in the UK may be unnecessarily taking drugs
Figures from NHS Digital show that more than 32million prescriptions were issued in England in 2018 for levothyroxine. This is up from 20,426,378 in 2008. (Source: the Mail online | Health)
Source: the Mail online | Health - May 15, 2019 Category: Consumer Health News Source Type: news

TSH and Pregnancy: Finding Your Way Out of the Gray Zone TSH and Pregnancy: Finding Your Way Out of the Gray Zone
Which patients with subclinical hypothyroidism in pregnancy would benefit from levothyroxine treatment? Dr Korevaar shares three tips to help guide the decision-making process.Endocrine Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 9, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology Commentary Source Type: news

ENDO: Levothyroxine Does Not Up Fertility in Women With TPO Ab
TUESDAY, March 26, 2019 -- For euthyroid women with thyroid peroxidase antibodies and a history of miscarriage or infertility, levothyroxine does not result in an increased rate of live births versus placebo, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 26, 2019 Category: Pharmaceuticals Source Type: news

Levothyroxine provides no pregnancy benefits to women with thyroid antibodies
According to data, presented at the Endocrine Society's annual meeting, euthyroid women treated with levothyroxine did not have improved chances of having a live birth, if they were also positive for thyroid antibodies.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - March 26, 2019 Category: Endocrinology Source Type: news

Levothyroxine Tx Doesn't Deliver in Women With TPO Antibodies
(MedPage Today) -- Preterm births and neonatal outcomes not significantly different than placebo (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - March 23, 2019 Category: OBGYN Source Type: news

Levothyroxine treatment in women with thyroid antibodies may not increase live birth rate
(University of Birmingham) Treating women with thyroid antibodies but a normal thyroid function with a medicine called Levothyroxine does not make them more likely to deliver a live baby, new research suggests. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 23, 2019 Category: International Medicine & Public Health Source Type: news

Levothyroxine treatment in women with thyroid antibodies may not increase live birth rate
(The Endocrine Society) Treating women who have thyroid antibodies, but normal thyroid function, with a medicine called Levothyroxine does not make them more likely to deliver a live baby, new research from the United Kingdom suggests. The research will be presented Saturday, March 23 at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La., and published in the New England Journal of Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 23, 2019 Category: International Medicine & Public Health Source Type: news

Levothyroxine Dosing: Morning, Night, or In Between? Levothyroxine Dosing: Morning, Night, or In Between?
Clinicians have traditionally told patients to take levothyroxine first thing in the morning, at least an hour before any food or drink. But does it really matter? Dr Leung looks at the evidence.Medscape Diabetes & Endocrinology (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 22, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology Article Source Type: news

Merck Wins Lawsuit on Levothyroxine Saga in France Merck Wins Lawsuit on Levothyroxine Saga in France
Merck has prevailed in a first lawsuit that claimed that switching the formulation of levothyroxine in France caused patients harm. The company still faces further claims, however.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 13, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

PCOS Gene Variants; Testosterone and CAD; New Generic Levothyroxine
(MedPage Today) -- News and commentary from the endocrinology world (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - December 28, 2018 Category: OBGYN Source Type: news

TH Status During Levothyroxine Therapy in Hypothyroidism TH Status During Levothyroxine Therapy in Hypothyroidism
Does levothyroxine therapy effectively restore thyroid hormone signaling in patients with overt hypothyroidism?Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 27, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Euthyrox (Levothyroxine Sodium Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 19, 2018 Category: Drugs & Pharmacology Source Type: news

Lannett signs $50M distribution deal; stock up 10 percent
Lannett Co. Inc. entered into an agreement Monday with Amneal Pharmaceuticals Inc., under which Amneal will be the sole customer for Lannett's levothyroxine sodium tablets. The deal calls for Lannett, a Northeast Philadelphia generic drug company, to receive an upfront payment of $50 million. Other terms of the transaction were not disclosed. Lannett's stock opened up 10 percent at $5.88 per share Monday morning. The deal comes about three months after Lannett (N YSE: LCI) announced Jerome Stevens… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 12, 2018 Category: Pharmaceuticals Authors: John George Source Type: news

Lannett Enters Into Agreement With Amneal Pharmaceuticals For Levothyroxine
Lannett Locks in $50 Million of Gross Profit for 16-Week Period PHILADELPHIA, Nov. 12, 2018 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an agreement with Amneal Pharmaceuticals... Biopharmaceuticals, Generics, Distribution Lannett Company, Amneal Pharmaceuticals, Levothyroxine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 12, 2018 Category: Pharmaceuticals Source Type: news

levothyroxine sodium (Synthroid, Levoxyl)
Title: levothyroxine sodium (Synthroid, Levoxyl)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 11/5/2018 12:00:00 AM (Source: MedicineNet Thyroid General)
Source: MedicineNet Thyroid General - November 5, 2018 Category: Endocrinology Source Type: news

The Love-Hate Relationship With Levothyroxine The Love-Hate Relationship With Levothyroxine
Levothyroxine, despite being the most prescribed drug in the United States, has many patients disenchanted and looking to T3 for symptom relief. How should clinicians approach the T4/T3 controversy?Medscape Diabetes & Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 25, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology Article Source Type: news